Purpose in the formula.
Discipline in the details.
The criteria guiding how we select ingredients, develop a product and communicate what is known.
Standards guiding development. Our first product is still in development and not available for purchase. These are our formulation requirements and working principles, not an independent certification or confirmation that every launch step is complete.
What we ask.
What we require.
A clearly identified source.
Specify the ingredient form and supplier rather than relying on a broad mineral name. For our first formula, we have selected Albion® TRAACS® magnesium bisglycinate ingredients from Balchem. Final raw-material specifications must match the formulation brief.
A defined formulation brief.
Our magnesium requirement is fully chelated and non-buffered, with no magnesium oxide. Final amounts, other ingredients and capsule materials must be confirmed before the formula is presented as complete.
A purpose for each component.
Consider the role of each ingredient in the formula, capsule or manufacturing process. Our preference is for a concise, purposeful ingredient list. This does not establish an excipient-free, additive-free or allergen-free product.
Manufacturing with documented expectations.
S.K. Labs is our selected U.S. manufacturing partner. The development process must clarify the final formula, product specifications, label requirements and applicable quality documentation. We will identify verified credentials individually rather than imply blanket certification.
Evidence read in context.
Review the subject, scope and limitations of research or testing. Supplier ingredient research, finished-product quality testing and clinical evidence answer different questions. One must not be presented as proof of another.
Clear, approved product information.
Publish the complete ingredient list, serving information, warnings and directions following final formula and label approval. Distinguish packaging concepts from the released label and development targets from confirmed product details.
A selected partner.
A defined process.
S.K. Labs is our selected U.S. manufacturing partner. Our work together focuses on confirming the formula, suitable packaging, label requirements and applicable quality documentation before launch.
Facility credentials and finished-product testing will be described according to the verified documents available. The image illustrates the manufacturing theme; it does not establish a facility certification or completed production.
Explore our quality commitment ↗Premium should be understandable.
Our goal is to bring a quality, accessible product to the U.S. market. For ALTIOMA, that means a defined ingredient source, considered formulation and information that makes the details easier to understand.
Design supports the experience. It does not replace evidence, product documentation or accurate labeling.
Our first formula.
A specific brief.
The bottle count is approved at 180 capsules. The current plan targets approximately 200 mg elemental magnesium per serving of three vegan capsules, equivalent to approximately 60 servings per bottle.
The amount refers to magnesium itself, not the total weight of the magnesium-containing compound. Serving details and capsule composition remain subject to final approval; this is not personal dosage advice.
Explore the ingredient details ↗The finished formula.
The approved label.
The verified documents.
Our standards are criteria for development. They do not mean a finished-product COA, heavy-metal report, independent certification or clinical study is already available.
Specific claims need specific support.
Certificates & reports
Identify the document, issuer and relevant scope. A laboratory report or batch COA is different from certification; none establishes every aspect of a product’s quality.
Ingredient & product
Explain when evidence concerns a supplier ingredient, a nutrient generally or the finished formula. An ingredient trademark is not proof of a guaranteed personal outcome.
Plans & completion
State the current status. A selected partner, planned test or packaging concept should not be presented as completed manufacturing, verified testing or a launched product.
A few useful distinctions.
Are these standards a third-party certification?
No. They describe ALTIOMA’s development requirements and principles. Any verified third-party certification would need to be identified separately with its applicable scope.
Does a concise formula mean no other ingredients?
No. Capsule materials and other ingredients can have necessary roles. The final list will be published after approval. We are not claiming an excipient-free formula.
What does U.S. manufacturing confirm?
Our selected manufacturing partner is located in the United States. This statement does not mean every raw material is U.S.-origin or establish a particular facility certification or FDA product approval.
Where will quality-document updates appear?
Our Quality Promise page describes the current status of applicable documents. Verified information will be added when available; no particular future certification is guaranteed.
Commitment meets context.
Read Quality Promise for our current project status and Science for how to interpret evidence.
Ask about our approach.
Contact our team for clarification about a specification, a statement or available documentation.
Contact us ↗